Terms: = Uterine cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
320 results:
1. Inclusion Complexes of
Pante GC; Castro JC; Lini RS; Romoli JCZ; Pires TY; Garcia FP; Nakamura CV; Mulati ACN; Matioli G; Machinski Junior M
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611905
[TBL] [Abstract] [Full Text] [Related]
2. Exploring genetic associations of Crohn's disease and ulcerative colitis with extraintestinal cancers in European and East Asian populations.
Yu C; Xu J; Xu S; Tang L; Han Q; Zeng X; Huang Y; Yu T; Sun Z
Front Immunol; 2024; 15():1339207. PubMed ID: 38404590
[TBL] [Abstract] [Full Text] [Related]
3. MRI Plain Scan: A Tool in the Management of Cervical cancer during Pregnancy.
Gao F; Qian T; Sun M; Lu Y; Cheng J; Fu L
Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389369
[TBL] [Abstract] [Full Text] [Related]
4. Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical cancer (COMPASSION-13): A Phase 2 Study.
Lou H; Cai H; Huang X; Li G; Wang L; Liu F; Qin W; Liu T; Liu W; Wang ZM; Li B; Xia Y; Wang J
Clin Cancer Res; 2024 Apr; 30(8):1501-1508. PubMed ID: 38372727
[TBL] [Abstract] [Full Text] [Related]
5. Immunotherapy for non-small cell lung cancer.
Kagamu H
Respir Investig; 2024 Mar; 62(2):307-312. PubMed ID: 38310751
[TBL] [Abstract] [Full Text] [Related]
6. An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.
Bikorimana JP; Abusarah J; Gonçalves M; Farah R; Saad W; Talbot S; Stanga D; Beaudoin S; Plouffe S; Rafei M
Cancer Sci; 2024 Apr; 115(4):1102-1113. PubMed ID: 38287511
[TBL] [Abstract] [Full Text] [Related]
7. An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical cancer.
Lukovic J; Pintilie M; Han K; Fyles AW; Bruce JP; Quevedo R; Pugh TJ; Fjeldbo CS; Lyng H; Milosevic MF
Clin Cancer Res; 2024 Mar; 30(6):1200-1207. PubMed ID: 38180733
[TBL] [Abstract] [Full Text] [Related]
8. The inflammatory response-related robust machine learning signature in endometrial cancer: Based on multi-cohort studies.
Zhou C; Xiang P; Xu X; Yue C; Gao K
J Gene Med; 2024 Jan; 26(1):e3603. PubMed ID: 37845174
[TBL] [Abstract] [Full Text] [Related]
9. Safety and antitumour activity of cadonilimab, an anti-PD-1/ctla-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Gao X; Xu N; Li Z; Shen L; Ji K; Zheng Z; Liu D; Lou H; Bai L; Liu T; Li Y; Li Y; Fan Q; Feng M; Zhong H; Huang Y; Lou G; Wang J; Lin X; Chen Y; An R; Li C; Zhou Q; Huang X; Guo Z; Wang S; Li G; Fei J; Zhu L; Zhu H; Li X; Li F; Liao S; Min Q; Tang L; Shan F; Gong J; Gao Y; Zhou J; Lu Z; Li X; Li J; Ren H; Liu X; Yang H; Li W; Song W; Wang ZM; Li B; Xia M; Wu X; Ji J
Lancet Oncol; 2023 Oct; 24(10):1134-1146. PubMed ID: 37797632
[TBL] [Abstract] [Full Text] [Related]
10. Pathogenomics model for personalized medicine in cervical cancer: Cross-talk of gene expressions and pathological images related to oxidative stress.
Li J; Chen S; Wu J; Liu X; Liu H; Liu Y; Zhu Z
Environ Toxicol; 2024 Feb; 39(2):751-767. PubMed ID: 37755325
[TBL] [Abstract] [Full Text] [Related]
11. Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer.
Li J; Wan C; Li X; Quan C; Li X; Wu X
J Transl Med; 2023 Sep; 21(1):647. PubMed ID: 37735483
[TBL] [Abstract] [Full Text] [Related]
12. Handheld vital microscopy for the identification of microcirculatory alterations in cervical intraepithelial neoplasia and cervical cancer.
Latul YP; Ince C; van Trommel NE; van den Brandhof-van den Berg A; Roovers JPWR; Kastelein AW
Microvasc Res; 2024 Jan; 151():104608. PubMed ID: 37690508
[TBL] [Abstract] [Full Text] [Related]
13. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract] [Full Text] [Related]
14. The anti-PD-1 era of cervical cancer: achievement, opportunity, and challenge.
Li C; Cang W; Gu Y; Chen L; Xiang Y
Front Immunol; 2023; 14():1195476. PubMed ID: 37559727
[TBL] [Abstract] [Full Text] [Related]
15. Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis.
Kim J; Jung JH; Jo H; Kim MH; Kang DR; Kim HM
Scand J Gastroenterol; 2023; 58(12):1412-1421. PubMed ID: 37517000
[TBL] [Abstract] [Full Text] [Related]
16. Landscape of PCOS co-expression gene and its role in predicting prognosis and assisting immunotherapy in endometrial cancer.
Zhang Y; Hu Y; Yu J; Xie X; Jiang F; Wu C
J Ovarian Res; 2023 Jul; 16(1):129. PubMed ID: 37393293
[TBL] [Abstract] [Full Text] [Related]
17. High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma.
Hao J; Liu T; Xiu Y; Yuan H; Xu D
Front Immunol; 2023; 14():1208223. PubMed ID: 37388735
[TBL] [Abstract] [Full Text] [Related]
18. Infection pattern and immunological characteristics of Epstein-Barr virus latent infection in cervical squamous cell carcinoma.
Zuo Y; Xiao H; Lv D; Huang M; Wang L; Liu J; Zhang K; Shen J; Wang Z; Wu Q; Xu Y
J Med Virol; 2023 Apr; 95(4):e28717. PubMed ID: 37184049
[TBL] [Abstract] [Full Text] [Related]
19. First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/ctla4 dual blocker, in patients with advanced solid tumors.
Zhao Y; Ma Y; Zang A; Cheng Y; Zhang Y; Wang X; Chen Z; Qu S; He J; Chen C; Jin C; Zhu D; Li Q; Liu X; Su W; Ba Y; Hao Y; Chen J; Zhang G; Qu S; Li Y; Feng W; Yang M; Liu B; Ouyang W; Liang J; Yu Z; Kang X; Xue S; Yang G; Yan W; Yang Y; Liu Z; Peng Y; Fanslow B; Huang X; Zhang L; Zhao H
J Hematol Oncol; 2023 May; 16(1):50. PubMed ID: 37158938
[TBL] [Abstract] [Full Text] [Related]
20. LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics.
Adashek JJ; Kato S; Nishizaki D; Miyashita H; De P; Lee S; Pabla S; Nesline M; Conroy JM; DePietro P; Lippman S; Kurzrock R
Cancer Med; 2023 Jun; 12(12):13155-13166. PubMed ID: 37132280
[TBL] [Abstract] [Full Text] [Related]
[Next]
